Physiological pharmacokinetics and cancer risk assessment
- 15 April 1993
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 69 (1) , 1-14
- https://doi.org/10.1016/0304-3835(93)90025-5
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Modeling Receptor‐Mediated Processes with Dioxin: Implications for Pharmacokinetics and Risk AssessmentRisk Analysis, 1993
- Comparison of three physiologically based pharmacokinetic models of benzene dispositionToxicology and Applied Pharmacology, 1991
- Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humansToxicology and Applied Pharmacology, 1991
- Risk extrapolation for chlorinated methanes as promoters vs initiators of multistage carcinogenesisFundamental and Applied Toxicology, 1990
- Physiologically based pharmacokinetics and the risk assessment process for methylene chlorideToxicology and Applied Pharmacology, 1987
- Inhalation pharmacokinetics: Evaluating systemic extraction, total in vivo metabolism, and the time course of enzyme induction for inhaled styrene in rats based on arterial blood:Inhaled air concentration ratiosToxicology and Applied Pharmacology, 1984
- Fate of 2,3,7,8-tetrachlorodibenzofuran in the monkeyToxicology and Applied Pharmacology, 1981
- Disposition and excretion of 2,3,7,8-tetrachlorodibenzofuran in the ratToxicology and Applied Pharmacology, 1980
- Methotrexate PharmacokineticsJournal of Pharmaceutical Sciences, 1971
- Quantitative Relations in the Physiological Constitutions of MammalsScience, 1949